Background
The supplied opinion is Justice Susanna Dokupil’s dissent in four consolidated original mandamus proceedings. The relators are Deloris Jones, individually and as representative of the Estate of Willie Lee Jones, Jr.; Wanda Brown, individually and as representative of the Estate of James Edward Brown; Russell Morris, individually and as representative of the Estate of Clarence James Morris; and Velma Duncan, individually and as representative of the Estate of Howard Moten, Sr. The majority opinion and its final disposition are not included in the supplied text. Accordingly, this summary addresses the dissent’s reasoning and proposed disposition, not a controlling judgment.
The dispute concerns Texas Civil Practice and Remedies Code section 90.010 and the circumstances in which older asbestos or silica personal-injury and death actions are subject to multidistrict-litigation rules. Section 90.010(a)(2) excepts certain pre-September 1, 2003 actions when a compliant physician’s report was served within 90 days after the chapter became law. Section 90.010(a)(3) separately excepts pre-September 1, 2003 actions involving diagnosed malignant mesothelioma, another malignant asbestos-related cancer, or malignant silica-related cancer. Subsection (b) permits a defendant to seek transfer when a qualifying report was not timely served and directs the MDL pretrial court to remand or retain jurisdiction depending on its report-related findings.
The trial court denied remand in 2018. It found that the actions predated September 2003, that no compliant report had been served within the statutory 90-day period, and that no report was filed until approximately 2017. It also stated that no evidence then showed a malignant-mesothelioma diagnosis and concluded that subsection (b) required a report even if such a diagnosis existed. After the First Court’s decision in Massachusetts Bay Insurance Co. v. Adkins, 615 S.W.3d 580 (Tex. App.—Houston [1st Dist.] 2020, no pet.), the relators obtained a physician’s report and renewed their remand request. The trial court again denied remand on July 17, 2024, stating that subsection (b) controlled over subsection (a), while expressing uncertainty about applying the 2005 legislation to a party added in 2017. It declined to specify whether subsection (a)(2) or (a)(3) applied.
The Court’s Holding
Justice Dokupil would deny mandamus. She stated the governing standard as requiring an abuse of discretion through a decision so arbitrary and unreasonable as to constitute clear and prejudicial legal error, or a clear failure to analyze or apply the law correctly, quoting In re Cerberus Capital Management, L.P., 164 S.W.3d 379, 382 (Tex. 2005) (orig. proceeding). She characterized section 90.010 as genuinely ambiguous but concluded that the trial court reached the correct result, even if its reasoning was incomplete.
The dissent agreed with the majority that no 90-day deadline should be implied in subsection (a)(3). It nevertheless reasoned that subsection (b) can control without importing that deadline into (a)(3). Relying on Adkins, 615 S.W.3d at 609–10 & n.9, Justice Dokupil explained that a claimant must serve the section 90.003 physician’s report even to invoke the malignant-disease exemption; absent that report, transfer to the MDL court may be proper. The report must confirm the qualifying diagnosis and that asbestos exposure caused the diagnosed disease, and it must be served on each defendant.
On the dissent’s reading, the timing of service relative to transfer is decisive. If a qualifying report had been served after the statute took effect in 2005 but before transfer in 2017, subsection (a)(3) would supply the starting point. Because no such report preceded transfer, the dissent would treat the transfer as valid and apply subsection (b)’s direction that the MDL court retain jurisdiction unless the timely-report exception in subsection (a)(2) requires remand. Justice Dokupil therefore read (a)(3) as blocking an invalid transfer, not as an indefinite, self-executing basis for remand after a valid transfer. She also observed that subsection (b) expressly references (a)(2), not (a)(3), and connected her construction with the MDL system’s purposes of “convenience, efficiency, and justice.”
The dissent distinguished In re GlobalSantaFe Corp., 275 S.W.3d 477 (Tex. 2008), noting that it addressed Jones Act preemption without directly resolving the interaction between subsections (a)(3) and (b). Because Justice Dokupil found no clear abuse of discretion, she would not reach whether an adequate appellate remedy existed. Her express conclusion was: “Mandamus should be denied. I dissent.”
Key Takeaways
- The supplied document is a dissent; it does not establish the majority’s holding or the consolidated proceedings’ actual final disposition.
- Justice Dokupil would deny mandamus because the trial court reached the correct result by retaining the cases in the MDL court.
- Her reading distinguishes a pre-transfer physician’s report, which could support subsection (a)(3), from a report first obtained after a valid transfer.
- She agreed that subsection (a)(3) contains no implied 90-day deadline, but would nevertheless apply subsection (b)’s retention provisions after a transfer based on a missing report.
Why It Matters
The dissent presents a detailed, timing-based construction of section 90.010 for legacy asbestos cases: service of a compliant physician’s report before transfer may prevent MDL transfer under the malignant-disease exemption, while service only after a valid transfer may not compel remand. It also illustrates how a court can reject an implied deadline in one statutory subsection while still giving controlling effect to another subsection’s transfer-and-retention mechanism.
Because the majority opinion is unavailable in the supplied material, attorneys should not treat this analysis as the court’s controlling resolution. The dissent’s immediate procedural significance is its stated preference to deny mandamus without reaching the adequate-remedy-by-appeal issue.